The Global Erectile Dysfunction Treatment Market, by Product (Viagra (Sildenafil citrate), Cialis (Tadalafil), Stendra/Sperda, Levitra/Staxyn, Zydena (Udenafil), and Vitaros (Alprostadil Cream)), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 4,946.2 million in 2018 and is expected to exhibit at a CAGR of 6.2% over the forecast period (2019–2027).
Frequent product launches and product approvals are expected to drive the global erectile dysfunction treatment market growth over the forecast period. The growing demand for treatment of erectile dysfunction has led to an increase in product launches by market players, which is expected to drive global erectile dysfunction treatment market growth during the forecast period.
Get PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-pdf/200
For instance, in September 2019, Lupin Limited launched Sildenafil tablets, USP of 25 mg, 50 mg, and 100 mg, a generic version of Pfizer Inc.’s Viagra tablets. Manufacturers are focused on receiving regulatory approvals for their products. For instance, in March 2019, Alembic Pharmaceuticals received the U.S. Food and Drug Administrational (FDA) approval for Tadalafil tablets that are used in treatment of erectile dysfunction. Moreover, in December 2017, Teva Pharmaceutical Industries Ltd. launched a generic version of Viagra (sildenafil citrate) tablets in the U.S. These sildenafil tablets are an affordable generic treatment option for erectile dysfunction. Furthermore, in June 2018, Camber Pharmaceuticals launched generic version of Viagra (sildenafil tablets) indicated for the treatment of erectile dysfunction. Camber Pharmaceuticals’ generic Viagra is available in 25, 50, and 100 mg dosage strengths.
To overcome challenges with treatment of ED and stigma about this disorder, companies are focusing on providing platform for easy availability of required medicines for people suffering from ED. For instance, in October 2017, Roman (a digital health clinic for men) launched a cloud-based pharmacy in California, New York, Florida, and Pennsylvania, especially for people suffering from erectile dysfunction.
Browse 33 Market Data, Tables, and 26 Figures spread through 171 Pages and in-depth TOC on The Global Erectile Dysfunction Treatment Market, by Product (Viagra (Sildenafil citrate), Cialis (Tadalafil), Stendra/Sperda, Levitra/Staxyn, Zydena (Udenafil), and Vitaros (Alprostadil Cream), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2027
To know the latest trends and insights prevalent in the global erectile dysfunction treatment market Press Release, click the link below: http://bit.ly/34RliFW
Key takeaways:
- The global erectile dysfunction treatment market is expected to exhibit a CAGR of 6.2% during the forecast period (2019–2027) owing to product launches and approvals.
- Among regions, North America is expected to hold the dominant position in the global erectile dysfunction treatment market over the forecast period owing to presence of major key players such as Pfizer Inc., Mylan Pharmaceuticals Inc., and others
- Increasing prevalence of erectile dysfunction is expected to drive demand for drugs such as Viagra, Cialis and others which are indicated for treatment of erectile dysfunction.
Some of the major players operating in the global erectile dysfunction treatment market include Mylan Pharmaceuticals Inc., Cipla Ltd., Aurobindo Pharma Ltd, Eli Lily & Co, Novartis International AG, Torrent Pharmaceuticals Ltd, Pfizer Inc., Bayer Pharma AG, Dr. Reddys Laboratories Ltd, and Dong-A Pharmaceutical Co., Ltd.
Direct Purchase the Erectile Dysfunction Treatment Market Report at @ https://www.coherentmarketinsights.com/insight/buy-now/200
Detailed Segmentation:
- Global Erectile Dysfunction Treatment Market, By Product:
- Viagra (Sildenafil citrate)
- Cialis (Tadalafil)
- Stendra/Spedra
- Levitra/Staxyn
- Zydena (Udenafil)
- Vitaros (Alprostadil Cream)
- Global Erectile Dysfunction Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: : sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
